Quoin Pharmaceuticals, Ltd.
SEC Filing List
QNRX CIK: 0001671502
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G/A | SEWARD & KISSEL LLP /fa | 05/15/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Quoin Pharmaceuticals, Ltd. | Toppan Merrill/FA | 05/07/2026 | |
| 8-K | Current report filing | Quoin Pharmaceuticals, Ltd. | Toppan Merrill/FA | 05/07/2026 | |
| SCHEDULE 13G/A | 04/29/2026 | ||||
| 4 | Statement of changes in beneficial owner... | Stonepine Capital Management, Llc | SHARTSIS FRIESE LLP /fa | 03/31/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Quoin Pharmaceuticals, Ltd. | Toppan Merrill/FA | 03/26/2026 | |
| 8-K | Current report filing | Quoin Pharmaceuticals, Ltd. | Toppan Merrill/FA | 03/26/2026 | |
| 8-K | Current report filing | Quoin Pharmaceuticals, Ltd. | Toppan Merrill/FA | 03/11/2026 | |
| SCHEDULE 13G | Toppan Merrill/FA | 02/17/2026 | |||
| SCHEDULE 13G | SCHULTE ROTH & ZABEL LLP /fa | 02/17/2026 | |||
| No record found. | |||||
| Load More | |||||
